Sumitomo Mitsui Trust Holdings, Inc. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sumitomo Mitsui Trust Holdings, Inc. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$111,311,728
-19.6%
3,520,295
+3.7%
0.09%
-15.7%
Q2 2023$138,434,072
+19.3%
3,394,656
+9.0%
0.11%
+25.6%
Q1 2023$116,020,168
+11.7%
3,112,964
+4.6%
0.09%
+4.9%
Q4 2022$103,832,710
-37.4%
2,976,002
+0.4%
0.08%
-39.7%
Q3 2022$165,861,000
+15.2%
2,963,928
+6.6%
0.14%
+22.5%
Q2 2022$143,952,000
-31.0%
2,781,136
-3.2%
0.11%
-20.1%
Q1 2022$208,728,000
-35.9%
2,872,269
+4.3%
0.14%
-29.8%
Q4 2021$325,621,000
+1.1%
2,753,903
+14.7%
0.20%
-1.5%
Q3 2021$321,951,000
-36.4%
2,399,933
-23.3%
0.20%
-32.8%
Q2 2021$506,390,000
+31.3%
3,127,603
-34.9%
0.30%
+24.1%
Q1 2021$385,809,000
+38.9%
4,807,294
-5.8%
0.24%
+34.6%
Q4 2020$277,677,000
+130.4%
5,104,362
-15.8%
0.18%
+121.0%
Q3 2020$120,523,000
-7.4%
6,062,516
-2.1%
0.08%
-12.0%
Q2 2020$130,223,000
+50.2%
6,195,189
-12.6%
0.09%
+22.7%
Q1 2020$86,726,000
-17.6%
7,091,263
-1.2%
0.08%
-9.6%
Q4 2019$105,309,000
+9.0%
7,178,520
-0.8%
0.08%
-1.2%
Q3 2019$96,650,000
+166.3%
7,239,737
+226.6%
0.08%
+162.5%
Q2 2019$36,287,000
+103.0%
2,216,660
+111.8%
0.03%
+88.2%
Q1 2019$17,877,0001,046,6920.02%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders